AMPC stem cell technology – one of the best solutions.

Unlock the Code to Youth – Reclaim Your Younger Self

AMPC Autologous Multipotent Stem Cell Therapy: A Comprehensive Inside-Out Anti-Aging Solution

Time never stops—but the visible signs of aging can be reversed.
AMPC Autologous Multipotent Stem Cell Therapy harnesses cutting-edge regenerative medicine to activate the body’s natural repair systems, restoring youthfulness from the inside out.

Each treatment is not just a repair—it’s a transformation.
From visible aging to rejuvenated vitality, experience the rebirth of your youth.

With AMPC Stem Cells, you don’t just look younger—you become younger.
Book your personalized consultation today and take the first step toward a truly ageless life.


In 2011, the Australian Therapeutic Goods Administration (TGA) classified AMPC as a product exempt from regulation under Therapeutic Goods Order No. 1 (2011).

Autologous multilineage potential cells (AMPC) have been utilized in over 2,000 treatments for various degenerative diseases.

AMPC is the only stem cell product in Australia covered by insurance. It is insured by Lloyd’s of London, and since 2011, there has never been a claim made.


Cells with potential multilineage differentiation ability and self-renewing capacity.

Cultivated from an individual’s own blood and separated from white blood cells.

AMPC demonstrates the ability to differentiate into various specialized cells in the body, such as:

➢ Neurons (ectoderm)
➢ Hepatocytes (endoderm)
➢ Osteoblasts (mesoderm)
➢ Cardiac cells (mesoderm)
➢ Renal cells (mesoderm)

These cells respond to the body’s chemical signals, identifying areas requiring stem cell regenerative effects for repair (homing effect).


  • Not only does it rejuvenate, its wide range of differentiation makes its therapeutic effects applicable to a variety of degenerative diseases, including arthritis, leukemia, cardiovascular disease, chronic kidney disease, liver disease and certain autoimmune diseases.
  • Homing effects determine preferential sites for regenerative effects.
  • Insurance coverage provides comprehensive protection for patients, medical staff, and AMPCs. No claims have been filed to date.

The most commonly used stem cells are:

Hematopoietic Stem Cells (HSCs): Transformed into blood cells and used in post-chemotherapy treatments.

Mesenchymal Stem Cells (MSCs): Used for joint/cartilage repair in sports injuries.

Embryonic Stem Cells: Not viable due to ethical concerns.

Induced Pluripotent Stem Cells (iPSCs): Genetically engineered.